The global pharmaceutical logistics market size is predicted to increase from USD 94.26 billion in 2024, grew to USD 102.56 billion in 2025 and is anticipated to reach around USD 219.1 billion by 2034, poised to grow at a CAGR of 8.80% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmaceutical Logistics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmaceutical Logistics Market, by Type, 2024-2034
8.1.1. Cold Chain Logistics
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Non-cold Chain Logistics
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Pharmaceutical Logistics Market, by Component, 2024-2034
9.1.1. Storage
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Transportation
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Monitoring components
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Pharmaceutical Logistics Market, by Application Type, 2024-2034
10.1.1. Bio Pharma
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Chemical Pharma
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Speciality Pharma
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. Pharmaceutical Logistics Market, by Procedure Type, 2024-2034
11.1.1. Picking
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Storage
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Retrieval Systems
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Handling Systems
11.1.4.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Component (2021-2034)
12.1.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.1.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Component (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Component (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Component (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Component (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Component (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Application Type (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)
13.1. FedEx
13.1.1. Company Overview
13.1.2. Product Offering
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Agility
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. CEVA Logistics
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Deutsche Post AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. VersaCold Logistics Services
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. LifeConEx
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Air Canada
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. United Parcel Service of America Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. DB Schenker
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Marken
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client